Exome Asset Management LLC Ionis Pharmaceuticals Inc Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
A detailed history of Exome Asset Management LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Exome Asset Management LLC holds 135,616 shares of IONS stock, worth $4.54 Million. This represents 3.64% of its overall portfolio holdings.
Number of Shares
135,616
Previous 61,367
120.99%
Holding current value
$4.54 Million
Previous $2.15 Billion
90.71%
% of portfolio
3.64%
Previous 1.61%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
401Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$549 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$542 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$414 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$346 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$282 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.76B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...